key: cord-1046278-duhfo3rx
authors: Nobrega de Almeida, João; Moreno, Lis; Francisco, Elaine Cristina; Noronha Marques, Gabriela; Mendes, Ana Verena; Barberino, Maria Goreth; Colombo, Arnaldo Lopes
title: Trichosporon asahii superinfections in critically ill COVID‐19 patients overexposed to antimicrobials and corticosteroids
date: 2021-06-16
journal: Mycoses
DOI: 10.1111/myc.13333
sha: 3644d70ca5ba922f7ed98b291bca9d0e807e8ec6
doc_id: 1046278
cord_uid: duhfo3rx

OBJECTIVES: To investigate the occurrence of Trichosporon asahii fungemia among critically ill COVID‐19 patients. METHODS: From 1 July to 30 September 2020, cases of T asahii fungemia (TAF) in a Brazilian COVID‐19 referral centre were investigated. The epidemiology and clinical courses were detailed, along with a mycological investigation that included molecular species identification, haplotype diversity analysis and antifungal susceptibility testing. RESULTS: Five critically ill COVID‐19 patients developed TAF in the period. All five patients had common risk conditions for TAF: central venous catheter at fungemia, previous exposure to broad‐spectrum antibiotics, prior echinocandin therapy and previous prolonged corticosteroid therapy. The average time of intensive care unit hospitalisation previous to the TAF episode was 23 days. All but one patient had voriconazole therapy, and TAF 30‐day mortality was 80%. The five T asahii strains from the COVID‐19 patients belonged to 4 different haplotypes, mitigating the possibility of skin origin and cross‐transmission linking the 5 reported episodes. The antifungal susceptibility testing revealed low minimal inhibitory concentrations for azole derivatives. CONCLUSIONS: Judicious prescription of antibiotics, corticosteroids and antifungals needs to be discussed in critically ill COVID‐19 patients to prevent infections by hard‐to‐treat fungi like T asahii.

50%. 3 In this scenario, the occurrence of T asahii fungemia (TAF) in COVID-19 hospitalised patients is worrisome and may contribute to increasing the mortality in this population. We report the epidemiology, clinical course and microbiological findings of T asahii fungemia episodes in COVID-19 patients hospitalised in an ICU from Salvador, Brazil.

The number of TAF and candidemia episodes per/1.000 ICU admissions was collected, as well as information regarding demographics underlying conditions, body mass index (BMI), previous antimicrobial exposure, previous antifungal exposure, antifungal breakthrough infection as defined by Cornely et al, 4 use of mechanical ventilation, use of renal replacement therapy, laboratory tests on admission and at fungemia, presence of invasive devices, previous bacterial or fungal infections and Pitt bacteremia score at fungemia for each TAF episode. 5, 6 Pitt bacteremia score was initially described for as a severity of acute illness in patients with bacteremia and also been applied as a prognostic evaluation in candidemia 6 and, recently, fungemia by Trichosporon spp. 7 Clinical management and 30-day outcome were also collected. The concomitance of COVID-19 pneumonia with TAF precluded any further analysis of lung involvement by the fungal pathogen. This study was approved by the Institutional Review Board, protocol number: 44674415.0.1001.5505.

Patients had SARS-CoV-2 detected in respiratory samples by RT-PCR after 24-48 h of admission (Allplex TM 2019-nCOV Assay).

Bactec (Becton and Dickinson) blood cultures and MALDI-TOF mass spectrometry (Vitek MS, bioMérieux) were used for the aetiologic diagnosis of sepsis. Molecular identification of Trichosporon spp. was confirmed by sequencing the IGS1 region from the rDNA. 8

To investigate the possibility of T asahii horizontal transmission among COVID-19 critically ill patients, we conducted a molecular investigation by multilocus DNA sequence analysis including the five T asahii epidemiologic-related clinical isolates and nine controls (2 reference strains and 7 unrelated isolates from the same hospital). Housekeeping genes from T asahii genomes (CBS2479 and CBS8904) available in GenBank (https://www.ncbi.nlm.nih.gov/) were aligned, and in silico analyses were carried out to design and evaluate the new primers. After PCR reactions and DNA sequence analysis, four loci with higher haplotypic diversity were selected for the multilocus phylogenetic analysis along with the IGS1 region from the rDNA: topoisomerase 1 (A1Q1_08199), phosphate carrier protein (A1Q1_08315), beta-1-tubulin (A1Q1_04313) and copperexporting ATPase (A1Q1_05365). Primers and PCR conditions are provided in Table 1 . DNA sequences from the five investigated loci were concatenated, and haplotype distribution was constructed by phylogenetic analysis using software MEGA X. 9 The five COVID-19-associated T asahii isolates had antifungal susceptibility testing 

Primer name Primer sequence Melting temp.

Corticosteroid therapy consisted of either methylprednisolone Trichosporon deep-seated infections were investigated, including eye fundoscopy, heart echocardiogram and abdominal ultrasound, but all cases were considered isolated fungemia. None of the patients had neutropenia (<500 cells/mm 3 ) before or at the TAF episode. One patient had a low blood lymphocyte count when TAF was diagnosed (300 cells/mm 3 ). The average Pitt bacteremia score at fungemia diagnosis was 11 (range 7-14). All but one patient had VRC therapy, either in monotherapy (n = 1) or combined with liposomal AMB (n = 3). One patient died before receiving antifungal therapy for the TAF episode. The overall 30-day mortality was 80%. The clinical course of the COVID-19 patients that developed TAF is summarised in Figure 1 and Table 2 .

The five T asahii strains from the COVID-19 patients belonged to 4 different haplotypes, mitigating the possibility of skin origin and crosstransmission linking the 5 reported episodes (Figure 2 ). GenBank accession numbers are available as appendix data ( 16 Thus, one has to keep in mind that direct enterocytes lesions by the SARS-CoV-2 may facilitate bacterial and fungal translocation from the digestive tract of some of these severely infected patients.

Despite the previous reports associating T asahii with horizontal transmission, 17 this event unlikely happened in this cohort. Some key elements against the hypothesis of horizontal transmission can be delineated as follows: patients had facilitating conditions for gut translocation and were exposed to echinocandins, which might have led to Trichosporon selection in the digestive tract; the molecular analysis showed a high haplotype diversity among the clinical isolates. The haplotype diversity translates genetic differences among the isolates, meaning that clonal dissemination which is suggestive of horizontal transmission did not occur in this cohort. These important observations raise the concern that critically ill COVID-19 patients may have a higher risk to develop Trichosporon fungemia and not only candidemia. Indeed, the incidence of Trichosporon fungemia in this study was at least six times higher than we previously reported in Brazilian centres. 18 For every 3.6 episodes of candidemia, one episode of TAF occurred in this cohort.

F I G U R E 2 (A) UPGMA phylogenetic tree showing the evolutionary relationship among 14 IGS1 nucleotide sequences, from two reference strains (CBS2479 and CBS2530) and 12 clinical strains from 10 patients from the same hospital. The strains 1533 2020 HSR and 1533B 2020 HSR were recovered from the same patient, as well as the strains 1537 2020 HSR and 1537B 2020 HSR. There were a total of 562 nucleotides positions in the final data set. The final tree with the sum of branch length = 0.0304 is shown. Three strains from different COVID-19 patients had identical sequences (1531 2020 HSR, 1534 2020 HSR, 1535 2020 HSR); (B) UPGMA phylogenetic tree showing the evolutionary relationship among 14 concatenated (five loci) nucleotide sequences, from two reference strains (CBS2479 and CBS2530) and 12 clinical strains from 10 patients from the same hospital. The strains 1533 2020 HSR and 1533B 2020 HSR were recovered from the same patient, as well as the strains 1537 2020 HSR and 1537B 2020 HSR. There were a total of 2467 nucleotides positions in the final data set. The final tree with the sum of branch length = 0.456 is shown. The strains recovered from the patients hospitalised at the COVID-19 ICU showed that only two patients had phylogenetic closely related strains (1534 2020 HSR and 1535 2020 HSR strains belong to the same haplotype)

We added evidence to the emerging issue regarding superinfections in severe COVID-19 patients. Judicious prescription of broadspectrum antibiotics, corticosteroids and antifungals needs to be discussed in critically ill COVID-19 patients to prevent infections not only by multidrug-resistant bacteria but also by hard-to-treat fungi like T asahii.

The study was partially supported by a grant received from Conselho 

Arnaldo Lopes Colombo https://orcid.org/0000-0003-0793-8491

COVID-19-associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions?

Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing

Invasive Trichosporon infection: a systematic review on a re-emerging fungal pathogen

Defining breakthrough invasive fungal infection-position paper of the mycoses study group education and research consortium and the European confederation of medical mycology

Predictive scoring model of mortality in Gram-negative bloodstream infection

The pitt bacteremia score, Charlson comorbidity index and chronic disease score are useful tools for the prediction of mortality in patients with candida bloodstream infection

Epidemiology, clinical aspects, outcomes and prognostic factors associated with Trichosporon fungaemia: results of an international multicentre study carried out at 23 medical centres

Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of trichosporon species

MEGA X: molecular evolutionary genetics analysis across computing platforms

Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts

Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres

Current knowledge of Trichosporon spp. and Trichosporonosis

Corticosteroids for COVID-19: the search for an optimum duration of therapy

Candida auris: a latent threat to critically ill patients with COVID-19

Bloodstream infection by saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of saccharomyces in the ICU

Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility

Trichosporon asahii among intensive care unit patients at a medical center in Jamaica

Correlation of Trichosporon asahii genotypes with anatomical sites and antifungal susceptibility profiles: data analyses from 284 isolates collected in the last 22 years across 24 medical centers